-
121
How to Calculate the Goodness-of-Fit of a Fractal Dimension
Published 2009-01-01Get full text
Article -
122
-
123
Effect of body orientation and joint movement on local bioimpedance measurements
Published 2024-10-01Get full text
Article -
124
Benefits management in software development: A systematic review of empirical studies
Published 2021-02-01Get full text
Article -
125
Shortened Cervix in the Subsequent Pregnancy after Embolization for Postpartum Cervical Hemorrhage
Published 2014-01-01Get full text
Article -
126
Worries and Concerns among Inflammatory Bowel Disease Patients Followed Prospectively over One Year
Published 2011-01-01Get full text
Article -
127
-
128
-
129
-
130
Patient safety culture through the lenses of surgical patients: a qualitative study
Published 2025-02-01Get full text
Article -
131
-
132
What Methods Software Teams Prefer When Testing Web Accessibility
Published 2019-01-01Get full text
Article -
133
Extending the concept of total pain to cancer survivorship
Published 2025-01-01Get full text
Article -
134
Imaging 3D Sea Surfaces from 3D Dual-Sensor Towed Streamer Data
Published 2013-01-01Get full text
Article -
135
-
136
-
137
-
138
Inflammatory Serum Protein Profiling of Patients with Lumbar Radicular Pain One Year after Disc Herniation
Published 2016-01-01“…All 45 patients were recruited from Oslo University Hospital, Ullevål, Norway, during the period 2007–2009. …”
Get full text
Article -
139
Stages of Change Model for Participation in Physical Activity during Pregnancy
Published 2013-01-01“…Healthy pregnant women (n=467) were allocated to the study from Oslo University Hospital, Norway. The participants filled in a validated self-administered questionnaire, physical activity pregnancy questionnaire (PAPQ) in gestation, weeks 32–36. …”
Get full text
Article -
140
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data St...
Published 2025-01-01“…Katarina Puco,1 Cathrine S Notland,2 Robert Szulkin,3,4 Christian Jonasson,5 Christian Beisland,6,7 Tom B Johannesen,8 Oddvar Solli,9 Jan Oldenburg,10,11 Daniel Heinrich12 1Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway; 2Department of Medical Affairs, Pfizer AS, Oslo, Norway; 3SDS Life Science, Stockholm, Sweden; 4Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden; 5Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 6Department of Urology, Haukeland University Hospital, Bergen, Norway; 7Department of Clinical Medicine, University of Bergen, Bergen, Norway; 8Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; 9Health and Value, Pfizer AS, Oslo, Norway; 10Department of Oncology, Akershus University Hospital HF, Lørenskog, Norway; 11Faculty of Medicine, University of Oslo, Oslo, Norway; 12Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, NorwayCorrespondence: Katarina Puco, Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway, Tel +47 416 86 298, Email katarina.puco@lds.noPurpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. …”
Get full text
Article